6533b822fe1ef96bd127d338
RESEARCH PRODUCT
PCV81 Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation
A.r. HarringtonE.p. ArmstrongP. NolanD.c. Malonesubject
year | journal | country | edition | language |
---|---|---|---|---|
Value in Health |